These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2833666)
21. Autoradiographic and SPECT imaging of cerebral opioid receptors with an iodine-123 labeled analogue of diprenorphine. Lever JR; Ilgìn N; Musachio JL; Scheffel U; Finley PA; Flesher JE; Natarajan TK; Wagner HN; Frost JJ Synapse; 1998 Jun; 29(2):172-82. PubMed ID: 9593107 [TBL] [Abstract][Full Text] [Related]
22. Investigation of the opioid system in absence seizures with positron emission tomography. Bartenstein PA; Duncan JS; Prevett MC; Cunningham VJ; Fish DR; Jones AK; Luthra SK; Sawle GV; Brooks DJ J Neurol Neurosurg Psychiatry; 1993 Dec; 56(12):1295-302. PubMed ID: 8270930 [TBL] [Abstract][Full Text] [Related]
23. Novel opiate binding sites selective for benzomorphan drugs. Chang KJ; Hazum E; Cuatrecasas P Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4141-5. PubMed ID: 6270660 [TBL] [Abstract][Full Text] [Related]
24. Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography. Frost JJ; Douglass KH; Mayberg HS; Dannals RF; Links JM; Wilson AA; Ravert HT; Crozier WC; Wagner HN J Cereb Blood Flow Metab; 1989 Jun; 9(3):398-409. PubMed ID: 2541148 [TBL] [Abstract][Full Text] [Related]
25. Opiate receptor: multiple effects of metal ions. Sadée W; Pfeiffer A; Herz A J Neurochem; 1982 Sep; 39(3):659-67. PubMed ID: 6284875 [No Abstract] [Full Text] [Related]
26. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study. Burn DJ; Rinne JO; Quinn NP; Lees AJ; Marsden CD; Brooks DJ Brain; 1995 Aug; 118 ( Pt 4)():951-8. PubMed ID: 7655890 [TBL] [Abstract][Full Text] [Related]
27. Dynamic monitoring of [11C]diprenorphine in rat brain using a prototype positron imaging device. Rajeswaran S; Hume SP; Cremer JE; Young J; Bailey DL; Ashburner J; Luthra SK; Jones AK; Jones T J Neurosci Methods; 1991 Dec; 40(2-3):223-32. PubMed ID: 1800857 [TBL] [Abstract][Full Text] [Related]
28. [3H]-etorphine and [3H]-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate. Kurowski M; Rosenbaum JS; Perry DC; Sadée W Brain Res; 1982 Oct; 249(2):345-52. PubMed ID: 6291717 [No Abstract] [Full Text] [Related]
29. 11C-diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping. Weeks RA; Cunningham VJ; Piccini P; Waters S; Harding AE; Brooks DJ J Cereb Blood Flow Metab; 1997 Sep; 17(9):943-9. PubMed ID: 9307607 [TBL] [Abstract][Full Text] [Related]
30. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Mayberg HS; Sadzot B; Meltzer CC; Fisher RS; Lesser RP; Dannals RF; Lever JR; Wilson AA; Ravert HT; Wagner HN Ann Neurol; 1991 Jul; 30(1):3-11. PubMed ID: 1656846 [TBL] [Abstract][Full Text] [Related]
31. Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Rinne JO; Burn DJ; Mathias CJ; Quinn NP; Marsden CD; Brooks DJ Ann Neurol; 1995 May; 37(5):568-73. PubMed ID: 7755350 [TBL] [Abstract][Full Text] [Related]
33. Opioid receptor imaging and displacement studies with [6-O-[11C] methyl]buprenorphine in baboon brain. Galynker I; Schlyer DJ; Dewey SL; Fowler JS; Logan J; Gatley SJ; MacGregor RR; Ferrieri RA; Holland MJ; Brodie J; Simon E; Wolf AP Nucl Med Biol; 1996 Apr; 23(3):325-31. PubMed ID: 8782244 [TBL] [Abstract][Full Text] [Related]
34. Preparation and biodistribution in mice of [11C]carfentanil: a radiopharmaceutical for studying brain mu-opioid receptors by positron emission tomography. Saji H; Tsutsumi D; Magata Y; Iida Y; Konishi J; Yokoyama A Ann Nucl Med; 1992 Feb; 6(1):63-7. PubMed ID: 1325823 [TBL] [Abstract][Full Text] [Related]
35. Opioid receptor PET reveals the psychobiologic correlates of reward processing. Schreckenberger M; Klega A; Gründer G; Buchholz HG; Scheurich A; Schirrmacher R; Schirrmacher E; Müller C; Henriksen G; Bartenstein P J Nucl Med; 2008 Aug; 49(8):1257-61. PubMed ID: 18632824 [TBL] [Abstract][Full Text] [Related]
36. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method. Richards ML; Sadée W Eur J Pharmacol; 1985 Aug; 114(3):343-53. PubMed ID: 2998812 [TBL] [Abstract][Full Text] [Related]
37. Binding characteristics of kappa opioids in rat brain. A comparison of in vitro binding paradigms. Weyhenmeyer JA; Mack KJ Neuropharmacology; 1985 Feb; 24(2):111-5. PubMed ID: 2986030 [TBL] [Abstract][Full Text] [Related]
38. Buprenorphine: differential interaction with opiate receptor subtypes in vivo. Sadée W; Rosenbaum JS; Herz A J Pharmacol Exp Ther; 1982 Oct; 223(1):157-62. PubMed ID: 6288917 [TBL] [Abstract][Full Text] [Related]
39. N-(3-[18F]fluoropropyl)-N-nordiprenorphine: synthesis and characterization of a new agent for imaging opioid receptors with positron emission tomography. Chesis PL; Hwang DR; Welch MJ J Med Chem; 1990 May; 33(5):1482-90. PubMed ID: 2158564 [TBL] [Abstract][Full Text] [Related]
40. In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding. Ruiz-Gayo M; Baamonde A; Turcaud S; Fournie-Zaluski MC; Roques BP Brain Res; 1992 Feb; 571(2):306-12. PubMed ID: 1319268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]